Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2005 1
2006 3
2008 2
2009 1
2010 1
2011 11
2012 5
2013 9
2014 3
2015 5
2016 10
2017 9
2018 7
2019 8
2020 5
2021 5
2022 12
2023 14
2024 12
2025 5
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial.
van den Heerik ASVM, Horeweg N, Haverkort MAD, Kuijsters N, Kommoss S, Koppe FLA, Nowee ME, Westerveld H, De Jong MAA, Frühauf F, Cnossen JS, Mens JWM, Beukema JC, Chargari C, Gillham C, Jurgenliemk-Schulz IM, Vandecasteele K, Hamann M, Kiderlen M, Staebler A, Nijman HW, Wortman BG, Asteinidou E, de Boer SM, van den Hout WB, Verhoeven-Adema KW, Nout RA, Putter H, Bosse T, Creutzberg CL. van den Heerik ASVM, et al. Among authors: staebler a. Lancet Oncol. 2026 Jan;27(1):23-35. doi: 10.1016/S1470-2045(25)00612-6. Lancet Oncol. 2026. PMID: 41449145 Clinical Trial.
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, Lebeau A, Liedtke C, von Minckwitz G, Nekljudova V, Schmatloch S, Schrenk P, Staebler A, Untch M. Kuehn T, et al. Among authors: staebler a. Lancet Oncol. 2013 Jun;14(7):609-18. doi: 10.1016/S1470-2045(13)70166-9. Epub 2013 May 15. Lancet Oncol. 2013. PMID: 23683750
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer.
Nelson BH, Hamilton P, Phung MT, Milne K, Harris B, Thornton S, Stevens D, Kalaria S, Singh K, Laumont CM, Moss E, Alimujiang A, Meagher NS, Bolithon A, Fereday S, Kennedy CJ, Hendley J, Ariyaratne D, Alsop K, Traficante N, Goode EL, Karnezis A, Shen H, Richardson J, McKinnonDeurloo C, Chase A, Grout B, Doherty JA, Harris HR, Cushing-Haugen KL, Anglesio M, Heinze K, Huntsman D, Talhouk A, Hanley GE, Alsop J, Jimenez-Linan M, Pharoah PD, Boros J, Brand AH, Harnett PR, Sharma R, Hecht JL, Sasamoto N, Terry KL, Karlan B, Lester J, Carney ME, Goodman MT, Hernandez BY, Wilkens LR, Behrens S, Turzanski Fortner R, Fasching PA, Bisinotto C, Candido Dos Reis FJ, Ghatage P, Köbel M, Elishaev E, Modugno F, Cook L, Le N, Gentry-Maharaj A, Menon U, García MJ, Rodriguez-Antona C, Farrington K, Kelemen LE, Kommoss S, Staebler A, Garsed DW, Brenton JD, Piskorz AM, Bowtell DD, DeFazio A, Ramus SJ, Pike MC, Pearce CL. Nelson BH, et al. Among authors: staebler a. J Clin Invest. 2024 Oct 29;134(24):e179501. doi: 10.1172/JCI179501. J Clin Invest. 2024. PMID: 39470729 Free PMC article.
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Zwimpfer TA, Fereday S, Pandey A, Ariyaratne D, Jayawardana MW, Twomey L, Laumont CM, Kennedy CJ, Bolithon A, Meagher NS, Milne K, Hamilton P, Alsop J, Antoniou AC, Au-Yeung G, Beckmann MW, Berrington de Gonzalez A, Bisinotto C, Blome F, Bodelon C, Boros J, Brand AH, Carney ME, Cazorla-Jiménez A, Chiu DS, Christie EL, Chudecka-Głaz A, Coulson P, Cushing-Haugen KL, Cybulski C, Darcy KM, David C, Davidson T, Ekici AB, Elishaev E, Emons J, Engler T, Farrell R, Fischer A, García-Closas M, Gentry-Maharaj A, Ghatage P, Glasspool R, Harter P, Hartkopf AD, Hartmann A, Heikaus S, Hernandez BY, Hettiaratchi A, Heublein S, Huntsman DG, Jimenez-Linan M, Jones ME, Kang E, Kaznowska E, Kluz T, Kommoss FKF, Konecny G, Kruitwagen RFPM, Kwon J, Lambrechts D, Lee CH, Lester J, Leung SCY, Leung Y, Linder A, Lissowska J, Loverix L, Lubiński J, Mateoiu C, McNeish IA, Moubarak M, Nelson GS, Nevins N, Olawaiye AB, Olbrecht S, Orsulic S, Osorio A, Quinn CM, Mohan GR, Ray-Coquard I, Rodríguez-Antona C, Roxburgh P, Ruebner M, Salfinger SG, Samra S, Schoemaker MJ, Sinn HP, Sonke GS, Steele L, Stewart CJR, Talhouk A, Tan A, Tarney CM, Taylor SE, Van de Vijver KK, van der Aa MA, Van Gorp T, Van Nieuwenhuysen … See abstract for full author list ➔ Zwimpfer TA, et al. Among authors: staebler a. medRxiv [Preprint]. 2025 Sep 22:2025.09.17.25335919. doi: 10.1101/2025.09.17.25335919. medRxiv. 2025. Update in: Nat Commun. 2026 Apr 1. doi: 10.1038/s41467-026-71134-3. PMID: 41040691 Free PMC article. Updated. Preprint.
Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifier.
Jamieson A, Grube M, Kommoss F, Lum A, Leung S, Chiu D, Henderson G, Heitz F, Heublein S, Zeimet AG, Hasenburg A, Diebold J, Walter C, Staebler A, Reynolds J, Lapuk A, McConechy MK, Huntsman DG, Gilks B, Kommoss S, McAlpine JN. Jamieson A, et al. Among authors: staebler a. Int J Gynecol Cancer. 2024 Dec 2;34(12):1888-1897. doi: 10.1136/ijgc-2024-005916. Int J Gynecol Cancer. 2024. PMID: 39461743 Free article.
Assessing the impact of deep-learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (STIC) in fallopian tubes.
Bogaerts JM, Steenbeek MP, Bokhorst JM, van Bommel MH, Abete L, Addante F, Brinkhuis M, Chrzan A, Cordier F, Devouassoux-Shisheboran M, Fernández-Pérez J, Fischer A, Gilks CB, Guerriero A, Jaconi M, Kleijn TG, Kooreman L, Martin S, Milla J, Narducci N, Ntala C, Parkash V, de Pauw C, Rabban JT, Rijstenberg L, Rottscholl R, Staebler A, Van de Vijver K, Zannoni GF, van Zanten M; AI‐STIC Study Group; de Hullu JA, Simons M, van der Laak JA. Bogaerts JM, et al. Among authors: staebler a. J Pathol Clin Res. 2024 Nov;10(6):e70006. doi: 10.1002/2056-4538.70006. J Pathol Clin Res. 2024. PMID: 39439213 Free PMC article.
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Garsed D, Zwimpfer T, Fereday S, Pandey A, Ariyaratne D, Jayawardana M, Twomey L, Laumont C, Kennedy C, Bolithon A, Meagher N, Milne K, Hamilton P, Alsop J, Antoniou A, Au-Yeung G, Beckmann M, de Gonzalez AB, Bisinotto C, Blome F, Bodelon C, Boros J, Brand A, Carney M, Cazorla-Jimenez A, Chiu D, Christie E, Chudecka-Glaz A, Coulson P, Cushing-Haugen K, Cybulski C, Darcy K, David C, Davidson T, Ekici A, Elishaev E, Emons J, Engler T, Farrell R, Fischer A, Garcia-Closas M, Gentry-Maharaj A, Ghatage P, Glasspool R, Harter P, Hartkopf A, Hartmann A, Heikaus S, Hernandez B, Hettiaratchi A, Heublein S, Huntsman D, Jimenez-Linan M, Jones M, Kang E, Kaznowska E, Kluz T, Kommoss F, Konecny GE, Kruitwagen R, Kwon J, Lambrechts D, Lee CH, Lester J, Leung S, Leung Y, Linder A, Lissowska J, Loverix L, Lubiński J, Mateoiu C, McNeish L, Moubarak M, Nelson G, Nevins N, Olawaiye A, Olbrecht S, Orsulic S, Osorio A, Quinn C, Mohan GR, Ray-Coquard I, Rodriguez-Antona C, Roxburgh P, Rübner M, Salfinger S, Samra S, Schoemaker M, Sinn HP, Sonke G, Steele L, Stewart C, Talhouk A, Tan A, Tarney C, Taylor S, Van de Vijver K, der Aa MA, Van Gorp T, Van Nieuwenhuysen E, van Wagensveld L, Wahner-Hendrickson A… See abstract for full author list ➔ Garsed D, et al. Among authors: staebler a. Res Sq [Preprint]. 2025 Oct 3:rs.3.rs-7572112. doi: 10.21203/rs.3.rs-7572112/v1. Res Sq. 2025. Update in: Nat Commun. 2026 Apr 1. doi: 10.1038/s41467-026-71134-3. PMID: 41255967 Free PMC article. Updated. Preprint.
The immunopeptidomic landscape of ovarian carcinomas.
Schuster H, Peper JK, Bösmüller HC, Röhle K, Backert L, Bilich T, Ney B, Löffler MW, Kowalewski DJ, Trautwein N, Rabsteyn A, Engler T, Braun S, Haen SP, Walz JS, Schmid-Horch B, Brucker SY, Wallwiener D, Kohlbacher O, Fend F, Rammensee HG, Stevanović S, Staebler A, Wagner P. Schuster H, et al. Among authors: staebler a. Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):E9942-E9951. doi: 10.1073/pnas.1707658114. Epub 2017 Nov 1. Proc Natl Acad Sci U S A. 2017. PMID: 29093164 Free PMC article.
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Zwimpfer TA, Fereday S, Pandey A, Ariyaratne D, Jayawardana MW, Twomey L, Laumont CM, Kennedy CJ, Bolithon A, Meagher NS, Milne K, Hamilton P, Alsop J, Antoniou AC, Au-Yeung G, Beckmann MW, Berrington de Gonzalez A, Bisinotto C, Blome F, Bodelon C, Boros J, Brand AH, Carney ME, Cazorla-Jiménez A, Chiu DS, Christie EL, Chudecka-Głaz A, Coulson P, Cushing-Haugen KL, Cybulski C, Darcy KM, David C, Davidson T, Ekici AB, Elishaev E, Emons J, Engler T, Farrell R, Fischer A, García-Closas M, Gentry-Maharaj A, Ghatage P, Glasspool R, Harter P, Hartkopf AD, Hartmann A, Heikaus S, Hernandez BY, Hettiaratchi A, Heublein S, Huntsman DG, Jimenez-Linan M, Jones ME, Kang E, Kaznowska E, Kluz T, Kommoss FKF, Konecny G, Kruitwagen RFPM, Kwon J, Lambrechts D, Lee CH, Lester J, Leung SCY, Leung Y, Linder A, Lissowska J, Loverix L, Lubiński J, Mateoiu C, McNeish IA, Moubarak M, Nelson GS, Nevins N, Olawaiye AB, Olbrecht S, Orsulic S, Osorio A, Quinn CM, Mohan GR, Ray-Coquard I, Rodríguez-Antona C, Roxburgh P, Ruebner M, Salfinger SG, Samra S, Schoemaker MJ, Sinn HP, Sonke GS, Steele L, Stewart CJR, Talhouk A, Tan A, Tarney CM, Taylor SE, Van de Vijver KK, van der Aa MA, Van Gorp T, Van Nieuwenhuysen … See abstract for full author list ➔ Zwimpfer TA, et al. Among authors: staebler a. Nat Commun. 2026 Apr 1. doi: 10.1038/s41467-026-71134-3. Online ahead of print. Nat Commun. 2026. PMID: 41922350 Free article.
120 results